Publications by authors named "Dan Weiner"

Article Synopsis
  • This study investigates the effects of a transdermal buprenorphine solution on horses, comparing its pharmacokinetics and antinociceptive properties with those of an intravenous (IV) injection, hypothesizing that transdermal application would yield more stable blood levels and fewer side effects.
  • Eight horses aged 6-12 were given incremental doses of the transdermal solution along with a single IV dose, with blood concentrations measured using advanced chromatography techniques, while various health indicators like heart rate and temperature were recorded to evaluate the drug’s effects.
  • Results showed that transdermal buprenorphine had low systemic concentrations (only 11% bioavailability) and provided inconsistent pain
View Article and Find Full Text PDF

Introduction: In March and April 2020 of the coronavirus disease 2019 pandemic, site clinical practice guidelines were implemented for prone positioning of patients with suspected coronavirus disease 2019 in hypoxic respiratory distress who are awake, alert, and spontaneously breathing. The purpose of this pandemic disaster practice improvement project was to measure changes in pulse oximetry associated with prone positioning of patients with coronavirus disease 2019 infection in adult acute respiratory distress or adult respiratory distress syndrome, who are awake, alert, spontaneously breathing, and nonintubated.

Methods: A retrospective chart review of patients who were coronavirus disease 2019 positive in the emergency department from March 30, 2020 to April 30, 2020 was conducted for patients with a room air pulse oximetry <90% and a preprone position pulse oximetry ≤94% who tolerated prone positioning for at least 30 minutes.

View Article and Find Full Text PDF

Most drug labels do not contain dosing recommendations for a significant portion of real-world patients for whom the drug is prescribed. Current label recommendations predominately reflect the population studied in pivotal trials that typically exclude patients who are very young or old, emaciated or morbidly obese, pregnant, or have multiple characteristics likely to influence dosing. As a result, physicians may need to guess the correct dose and regimen for these patients.

View Article and Find Full Text PDF